Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading ...

According to Lilly, the trial revealed that Zepbound achieved a 47% greater relative weight loss compared to Wegovy. On average, participants using Zepbound lost 20.2% of their body weight, while ...

Paxton's office said the company supplied free nurses to help care for patients who received its drugs, as well as ...

"Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs" was originally created and published by Pharmaceutical ...

Over 2,000 Ozempic and Zepbound lawsuits allege life-threatening side effects as FDA updates warnings and courts weigh ...

Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from ...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro. Lilly claims ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes ...

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro By Angelica Peebles, CNBC • Published April 1, 2025 • Updated on April 21, 2025 at 3:00 pm ...